Evidence map›Paper›PMID 41329650›Full record

SynthesisPloS one2025

The epidemiology and management of chronic osteomyelitis in pediatrics - A systematic review.

Joan L Robinson, Deema Gashgarey, Nourah Alruqaie, Liz Dennett, M Elizabeth Pedersen

Abstract readSystematic Review
In one paragraph

Synthesis in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Osteomyelitis.Nature reviews. Disease primers · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joan L RobinsonDepartment of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.ORCID https://orcid.org/0000-0001-9831-5681
Deema GashgareyDepartment of Pediatrics, University of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-2655-8809
Nourah AlruqaieDepartment of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Liz DennettGeoffrey and Robyn Sperber Health Sciences Library, University of Alberta, Edmonton, Alberta, Canada.
M Elizabeth PedersenDepartment of Orthopedic Surgery, University of Alberta, Edmonton, Alberta, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesInfection leading to necrosis of any bone can lead to chronic osteomyelitis (CO), sometimes resulting in permanent orthopedic sequelae. There are no published guidelines on the optimal management of adult or pediatric CO The objective of this study was to analyze published evidence for the epidemiology and management of pediatric CO.

methodsInclusion criteria were studies of any design (minimum 2 patients) in any language that included patients with CO up to 17 years of age and described the epidemiology or management of CO. Ovid Medline(R) ALL, Embase (via Ovid), CINAHL Plus with Full Text (via EBSCOhost) and Scopus were screened Jan 1, 1989 to Feb 13, 2025. Quality assessment was based on the degree of bias if one were to use that study to make decisions about management of CO. Studies were divided into those from middle-high and high-income countries versus studies from lower income countries. Data were extracted on demographics, biomarkers, pathogens, treatments offered, recurrences and orthopedic sequelae.

resultsThere were 41 included studies - 26 from middle-high- and high-income countries (904 cases total) and 15 from lower income countries (975 cases total). All were observational and only 19 of the 41 studies reported 7 or 8 of the 8 items deemed essential to make decisions about management of CO. Definitions of CO varied markedly. Analyzing the 17 studies that included a minimum of 10 consecutive cases, 627 of 1073 cases (58%) occurred in males. In these 17 studies, the tibia or femur accounted for 630 of 934 cases (67%). In 212 of 287 cases (74%) with a single pathogen reported, that pathogen was Staphylococcus aureus. There were no apparent differences in sex, bones involved or pathogens by country income level. Most cases (with the notable exception of those in recent case series from the United States) were managed with debridement. This was typically followed by sequential intravenous/per os (IV/ PO) antibiotics with almost no patients managed with PO antibiotics alone. Twelve case series reported use of local antibiotic delivery in addition to systemic antibiotics, but none of these studies had a control group. Studies were too heterogeneous in design to allow for data to be directly compared or combined. However, there was no obvious relationship between the route or duration of antimicrobials and the incidence of recurrences or orthopedic sequalae.

conclusionThere is a great need for high quality studies of all aspects of diagnosis and treatment of CO. Empiric coverage should target S. aureus. The evidence is poor quality, but there is no evidence that prolonged courses of antibiotics prevent recurrences.

Indexed as

OsteomyelitisAdolescentAnti-Bacterial AgentsChildChronic DiseaseDisease ManagementHumansMaleAnti-Bacterial Agents

Identifiers

PMID41329650
PMCPMC12671803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.